Results 181 to 190 of about 1,180,256 (306)

InCytokine, an Open-Source Software, Reveals a TREM2 Variant-Specific Cytokine Signature. [PDF]

Int J Mol Sci
Jha D, Ancona M, Oplt F, Farmer SL, Vagenknecht M, Vazquez-Otero A, Prazdnyk I, Soukup J, Mathew RS, Peterson V, Bitton DA.   +10 more
europepmc   +1 more source

Complementarity of Long‐Reads and Optical Mapping in Parkinson's Disease for Structural Variants

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Long‐read sequencing and optical genome mapping technologies have the ability to detect large and complex structural variants. This has led to the discovery of novel pathogenic variants in neurodegenerative movement disorders. Thus, we aimed to systematically compare the SV detection capabilities of OGM and ONT in Parkinson's disease.
André Fienemann, Theresa Lüth, Susen Schaake, Carolin Gabbert, Marius Möller, Hauke Busch, Katja Lohmann, Jonas A. Gustafson, Danny E. Miller, Kensuke Daida, Manabu Funayama, Nobutaka Hattori, Samia Ben Sassi, Faycel Hentati, Matthew J. Farrer, Kristian K. Ullrich, Christine Klein, Joanne Trinh   +17 more
wiley   +1 more source

Vis-OCT Explorer: an open-source software for visible-light optical coherence tomography data processing. [PDF]

Biomed Opt Express
Fan W, Xu F, Kuranov R, Zambrano R, Chen J, Lavinsky F, Wu J, Lee SH, Trang KQ, Mirza R, Simon S, Liu X, Goldberg JL, Huang AS, Schuman JS, Zhang HF.   +15 more
europepmc   +1 more source

A Systematic Review and Meta‐Analysis of the Recurrence of Autoimmune Encephalitis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Autoimmune encephalitis (AE) is a disease with a potential for recurrence, and patients receive immunotherapy to prevent it. However, there is no consensus on the duration of immunotherapy. This study aimed to determine the recurrence rate and identify the risk factors for AE to provide guidance on the duration of immunotherapy ...
Shangkai Bai, Sen Zhang, Haipei Zhang, Yating Zhang, Junhong Guo, Xiaoyan Yang   +5 more
wiley   +1 more source

SurprisalAnalysis: an open-source software for information-theoretic analysis of gene expression. [PDF]

Bioinform Adv
Najafi A.
europepmc   +1 more source

Location‐Specific Hematoma Volume Predicts Early Neurological Deterioration in Supratentorial ICH

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Early neurological deterioration (END) adversely affects outcomes in patients with intracerebral hemorrhage (ICH). This study aimed to determine the location‐specific hematoma volumes for END in supratentorial ICH patients. Methods We retrospectively analyzed supratentorial ICH patients presenting from two prospective cohorts.
Zuoqiao Li, Guilin Meng, Zijie Wang, Xiao Hu, Jing Cheng, Chu Chen, Tiannan Yang, Jiaxin Luo, Zizhen Meng, Xueyun Liu, Qi Li   +10 more
wiley   +1 more source

Perspectives on Free and Open Source Software

SCRIPTed: A Journal of Law, Technology & Society, 2006
Andres Guadamuz
doaj   +1 more source

GelInsight: Open-source software for large-sample DNA fragmentation quality control in gel electrophoresis images. [PDF]

PLoS One
Bautista KJB, Mehrab-Mohseni M, Kiradoh SA, Dayton PA, Pattenden SG.   +4 more
europepmc   +1 more source

Clinical Validation of Plasma p‐217tau in Neurological Diseases

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Plasma p‐217tau is a minimally invasive but specific biomarker for diagnosing Alzheimer's disease (AD). However, its disease specificity remains to be clinically evaluated. We validated the reliability of the p‐217tau biomarker in 12 other neurological diseases.
Takeshi Kawarabayashi, Takumi Nakamura, Ryoma Takahashi, Tetsuya Ueda, Seiji Kinoshita, Chikage Uchida, Takashi Sugawara, Kentaro Hashimoto, Kunihiko Ishizawa, Masakuni Amari, Hiroo Kasahara, Yoshio Ikeda, Masamitsu Takatama, Mikio Shoji   +13 more
wiley   +1 more source

ODIASP: An Open-Source Software for Automated SMI Determination-Application to an Inpatient Population. [PDF]

J Cachexia Sarcopenia Muscle
Charrière K, Ragusa A, Genoux B, Vilotitch A, Artemova S, Dumont C, Beaudoin PA, Madiot PE, Ferretti GR, Bricault I, Fontaine E, Bosson JL, Moreau-Gaudry A, Giai J, Bétry C.   +14 more
europepmc   +1 more source